Documentation and Data Integrity in Pharmaceutical Industry

The pharmaceutical industry is growing at a rapid rate and experiencing a wide gamut of changes in the process. Various aspects of the manufacturing process precipitate large volumes of data and information. Management of such data is essential for the smooth and efficacious functioning of any pharmaceutical unit. Additionally, it also poses the problem of maintaining reliability and traceability of the data. This has led to several regulatory bodies generating the principles of Data Integrity (DI). Data integrity (DI) refers to the guarantee that data records are accurate, whole, undamaged, and kept in the original context. It additionally encompasses how the data sets are linked to other pertinent records and focuses on avoiding unintentional modifications to the confidential information. This topic aims to explore the tenets of DI and their efficient implementation. This includes currently accepted standards of DI and the ALCOA+ principles. It also explores the guidelines put in place by regulatory authorities of various countries. Another important aspect of data management this article traverses is documentation and the associated Good Documentation Practices (GDP) required in the pharmaceutical industry. Adhering to GDP ensures transparency and traceability of data. This article discusses the various emerging trends and technologies in the same, and their ramifications on the growth of the industry.